Bausch + Lomb

This trial evaluates whether REVIVE toric soft contact lenses can effectively correct vision in adults with astigmatism. Participants wear the lenses daily for about a week, and researchers measure visual acuity at a follow-up visit. The study aims to assess the lenses' performan…

This Phase 2 trial tests an experimental eye drop called BL1107 against a standard treatment (timolol) in 252 adults with glaucoma or high eye pressure. Participants use the drops twice daily for 28 days. The study measures changes in vision and eye pressure to see if BL1107 is s…

This study tests a new type of artificial lens (enVista Beyond) for people having cataract surgery. The lens is designed to improve intermediate vision, like seeing a computer screen, while still providing good distance and near vision. About 304 adults will receive the lens in b…

This study tests whether Miebo eye drops, used before and after cataract surgery, can improve the accuracy of lens measurements and final vision in people with dry eye. Participants apply the drops four times daily for about 30 days before surgery and again for 30 days after. The…

This study looked at how well enVista Aspire intraocular lenses work in real-world cataract surgery. 335 adults received the lenses during routine cataract removal. Researchers measured vision sharpness and how satisfied patients and surgeons were with the results.

Researchers compare kalifilcon A daily disposable toric contact lenses with Ultra for Astigmatism lenses in adults who already wear soft contacts and need astigmatism correction. Each participant wears both lens types for about one week each, in random order. The study measures h…

This study tests whether BL1332 eye drops can reduce eye pain caused by capsaicin (the spicy ingredient in chili peppers) in healthy adults aged 18 to 65. Participants receive either BL1332 or a placebo eye drop, and then rate their pain on a 0-to-10 scale. The goal is to see if …

This trial tests whether Biotrue ONEday contact lenses packaged with a new solution (EPG03) provide the same clear vision as the standard lenses. Adults who normally wear contact lenses will try both versions for two hours, and researchers will measure visual sharpness. The goal …

This trial tests whether a new daily disposable multifocal contact lens (kalifilcon A) can provide clear vision at both distance and near compared to an existing lens (samfilcon A) in people with presbyopia, the age-related loss of near vision. Adults aged 40 and older who alread…

This Phase 2 trial tests a new eye drop that combines two active ingredients—lifitegrast and perfluorohexyloctane—for people with dry eye disease. About 423 adults will use the drops twice daily for 4 weeks. Researchers will measure changes in eye surface staining and symptom sco…

This completed Phase 3 trial tested a new eye drop containing brimonidine and sodium hyaluronate against Lumify for reducing eye redness in 578 adults. Participants used the drops four times daily, and redness was measured over several hours. The goal was to see if the new drop w…

This study tested whether Miebo eye drops (perfluorohexyloctane) can safely and effectively relieve dry eye symptoms in people who wear soft contact lenses. 104 adults used the drops up to four times daily, both before and while wearing their lenses. Researchers measured changes …

This study tested Miebo eye drops in 99 adults with dry eye disease. Participants used one drop in each eye four times daily for 14 days. The main goal was to see how much dry eye symptoms improved after one week, measured on a 0-to-100 scale. The study is complete, but results a…

This study investigates how three different daily disposable contact lenses—kalifilcon A, Dailies Total1, and Precision1—affect the lens surface when worn. Ten habitual contact lens wearers will wear each lens type for short periods, and researchers will measure the surface refra…